Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
2.
Mol Neurobiol ; 55(9): 7555-7566, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29429048

RESUMEN

Apathy is observed across several neurological and psychiatric conditions; however, its pathogenesis remains unclear. We clarified the involvement of brain-gut signaling in the disruption of goal-directed behavior. Male C57BL/6J mice were exposed to water immersion (WI) stress for 3 days. Food intake and nesting behavior were measured as indexes of motivation. Repeated WI caused decrease in food intake and nesting behavior. Plasma levels of peptide YY (PYY), IL-6, and ratio of dopamine metabolites in the striatum were significantly elevated after WI. PYY and IL-6 administration significantly decreased nesting behavior. The reductions in feeding and nesting behavior were blocked by PYY receptor (Y2R) antagonist or dopamine agonist. The ameliorative effect of the Y2R antagonist was diminished by the dopamine D2 receptor (D2R) antagonist. The reduction in goal-directed behavior is associated with dysfunction of D2R signaling via increased peripheral PYY, suggesting that PYY antagonism is a novel candidate for decline of motivation in several depressive diseases.


Asunto(s)
Apatía , Conducta Animal , Inmersión , Péptido YY/metabolismo , Receptores de Dopamina D2/metabolismo , Agua , Animales , Apatía/efectos de los fármacos , Peso Corporal , Corticosterona/sangre , Dopamina/metabolismo , Ingestión de Alimentos , Regulación de la Expresión Génica , Humanos , Hipotálamo/metabolismo , Interleucina-6/administración & dosificación , Interleucina-6/farmacología , Masculino , Ratones Endogámicos C57BL , Modelos Biológicos , Comportamiento de Nidificación , Tamaño de los Órganos , Péptido YY/administración & dosificación , Péptido YY/farmacología , Receptores de Neuropéptido Y/antagonistas & inhibidores , Receptores de Neuropéptido Y/metabolismo
3.
Funct Neurol ; 33(4): 213-216, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30663968

RESUMEN

Post-stroke apathy is considered to be one of the clinical consequences of lesions affecting the structures of the prefrontal cortex, basal ganglia, thalamus and limbic system. However, there is no current consensus on the treatment of post-stroke apathy, which mainly depends on the underlying etiology and comorbidities. A 62-year-old man, affected by hemorrhagic stroke in the left thalamus, presented with mood depression, anhedonia, hyporexia and marked apathy. The patient underwent clinical evaluation before and after receiving two different pharmacological therapies: escitalopram and bupropion. Only after treatment with the latter drug did the patient show changes: high motivation and willingness to pursue activities, greater interest in the external environment and social life activities, and an overall reduction of apathy. On the basis of our observations in this case, we hypothesize that the thalamic lesion resulted in disconnection of the fronto-striatal-thalamic circuits, and that loss of the dopaminergic striatal innervation caused the patient's apathetic state. The resolution of the apathetic disorder may be attributable to the action of the dopaminergic drug bupropion on the mesocortical pathway.


Asunto(s)
Antidepresivos de Segunda Generación/farmacología , Apatía/efectos de los fármacos , Bupropión/farmacología , Accidente Cerebrovascular , Tálamo , Antidepresivos de Segunda Generación/administración & dosificación , Bupropión/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Accidente Cerebrovascular/complicaciones , Accidente Cerebrovascular/patología , Accidente Cerebrovascular/fisiopatología , Tálamo/efectos de los fármacos , Tálamo/patología , Tálamo/fisiopatología
4.
Psychopharmacology (Berl) ; 235(2): 481-490, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-28735368

RESUMEN

BACKGROUND: MDMA has been shown to induce feelings of sociability, a positive emotional bias and enhanced empathy. While previous research has used only visual emotional stimuli, communication entails more than that single dimension and it is known that auditory information is also crucial in this process. In addition, it is, however, unclear what the neurobiological mechanism underlying these MDMA effects on social behaviour is. Previously, studies have shown that MDMA-induced emotional excitability and positive mood are linked to the action on the serotonin (5-HT) 2A receptor. AIM: The present study aimed at investigating the effect of MDMA on processing of sounds (Processing of Affective Sounds Task (PAST)) and cognitive biases (Approach-Avoidance Task (AAT)) towards emotional and social stimuli and the role of 5-HT2A receptor in these effects. METHODS: Twenty healthy recreational users entered a 2 × 2, placebo-controlled, within-subject study with ketanserin (40 mg) as pre-treatment and MDMA (75 mg) as treatment. Behavioural (PAST, AAT) measures were conducted 90 min after treatment with MDMA, respectively, 120 min after ketanserin. Self-report mood measures and oxytocin concentrations were taken at baseline and before and after behavioural tests. RESULTS: Findings showed that MDMA reduced arousal elicited by negative sounds. This effect was counteracted by ketanserin pre-treatment, indicating involvement of the 5-HT2 receptor in this process. MDMA did not seem to induce a bias towards emotional and social stimuli. It increased positive and negative mood ratings and elevated oxytocin plasma concentrations. The reduction in arousal levels when listening to negative sounds was not related to the elevated subjective arousal. CONCLUSION: It is suggested that this decrease in arousal to negative stimuli reflects potentially a lowering of defences, a process that might play a role in the therapeutic process.


Asunto(s)
Estimulación Acústica/efectos adversos , Apatía/fisiología , N-Metil-3,4-metilenodioxianfetamina/farmacología , Receptor de Serotonina 5-HT2A/fisiología , Serotoninérgicos/farmacología , Sonido/efectos adversos , Estimulación Acústica/psicología , Adulto , Afecto/efectos de los fármacos , Afecto/fisiología , Apatía/efectos de los fármacos , Método Doble Ciego , Emociones/efectos de los fármacos , Emociones/fisiología , Femenino , Humanos , Masculino , Autoinforme
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA